Delivery Order SPE2DB20D3104-SPE2DB26FV3Q9
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 16, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This is a firm fixed-price contract with a ceiling value of $1,797.10 and an ultimate completion date of July 17, 2025. The award was made through open competition with no set-aside designation. The place of performance is located in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,186.16 by the Defense Logistics Agency on July 22, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is set for July 23, 2025, with performance occurring at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $1,768.36. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, with performance scheduled for...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $20,029.67. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,931.20 by the Defense Logistics Agency on July 18, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packaging). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award through open procurement. The place of performance is listed as Conshohocken, PA, and the delivery order is scheduled...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 22, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $32,285.78. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, was competitively awarded without set-aside designation and represents performance at the contractor's corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packages) with a ceiling value of $38,436.76. This firm fixed-price delivery order, which has an ultimate completion date of April 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packages) with a ceiling value of $1,570.80. This is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and no set-aside designation was used in the award. The contract represents a competitive procurement action within the pharmaceutical supply chain...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,131.67 on October 24, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by October 27, 2025, with the place of performance at AmerisourceBergen's corporate office in Conshohocken. The delivery order was issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $20,323.56. This is a firm fixed price delivery order with an ultimate completion date of October 17, 2025, and represents a non-competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB26FV3Q9Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,995.06 by the Defense Logistics Agency on October 27, 2025, for the supply of Eliquis 5 mg tablets (60-count). The contract is a firm fixed price delivery order with an ultimate completion date of October 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/27/25 |